Article
Genetically based resistance to the antiinflammatory effects of methotrexate in the air-pouch model of acute inflammation.
Arthritis and rheumatism - 1 Aug 2005
Delano David L, Montesinos M Carmen, Desai Avani, Wilder Tuere, Fernandez Patricia, D'Eustachio Peter, Wiltshire Tim, Cronstein Bruce N
Abstract excerpt
OBJECTIVE: Low-dose methotrexate (MTX), a mainstay in the treatment of rheumatoid arthritis, is effective in only 60-70% of patients, a finding mirrored by poor antiinflammatory efficacy in some animal models, most notably collagen-induced arthritis. To determine whether genetic factors or the model itself is responsible for the poor response to MTX, we directly compared the responses of 4 inbred mouse strains to...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
